# MiraLAX

NDC: 11523-7341
Generic name: Polyethylene Glycol 3350
Labeler / Manufacturer: Bayer HealthCare LLC.
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20070201

FDA application: NDA022015

## Active ingredients

- POLYETHYLENE GLYCOL 3350: 17 g/17g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11523-7341"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11523-7341
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d69ce3d4-7ca4-4fe3-b49e-6655e48d6963